199 related articles for article (PubMed ID: 27718511)
41. Quercetin Attenuates Visceral Hypersensitivity and 5-Hydroxytryptamine Availability in Postinflammatory Irritable Bowel Syndrome Rats: Role of Enterochromaffin Cells in the Colon.
Qin HY; Zang KH; Zuo X; Wu XA; Bian ZX
J Med Food; 2019 Jul; 22(7):663-671. PubMed ID: 30920336
[TBL] [Abstract][Full Text] [Related]
42. Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.
Theodorou V; Ait Belgnaoui A; Agostini S; Eutamene H
Gut Microbes; 2014; 5(3):430-6. PubMed ID: 25184834
[TBL] [Abstract][Full Text] [Related]
43. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
44. Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.
Eutamene H; Bradesi S; Larauche M; Theodorou V; Beaufrand C; Ohning G; Fioramonti J; Cohen M; Bryant AP; Kurtz C; Currie MG; Mayer EA; Bueno L
Neurogastroenterol Motil; 2010 Mar; 22(3):312-e84. PubMed ID: 19706070
[TBL] [Abstract][Full Text] [Related]
45. Antinociceptive Effects of an Anti-CGRP Antibody in Rat Models of Colon-Bladder Cross-Organ Sensitization.
Noor-Mohammadi E; Ligon CO; Mackenzie KD; Stratton J; Shnider SJ; Greenwood-Van Meerveld B
J Pharmacol Exp Ther; 2023 Oct; 387(1):4-14. PubMed ID: 37164371
[TBL] [Abstract][Full Text] [Related]
46. Probiotic Lactobacillus rhamnosus GG (LGG) and prebiotic prevent neonatal inflammation-induced visceral hypersensitivity in adult rats.
Kannampalli P; Pochiraju S; Chichlowski M; Berg BM; Rudolph C; Bruckert M; Miranda A; Sengupta JN
Neurogastroenterol Motil; 2014 Dec; 26(12):1694-704. PubMed ID: 25298006
[TBL] [Abstract][Full Text] [Related]
47. Colonic mast cell infiltration in rats with TNBS-induced visceral hypersensitivity.
Ohashi K; Sato Y; Iwata H; Kawai M; Kurebayashi Y
J Vet Med Sci; 2007 Dec; 69(12):1223-8. PubMed ID: 18176016
[TBL] [Abstract][Full Text] [Related]
48. Oral administration of Lactobacillus casei variety rhamnosus partially alleviates TMA-induced atopic dermatitis in mice through improving intestinal microbiota.
Yeom M; Sur BJ; Park J; Cho SG; Lee B; Kim ST; Kim KS; Lee H; Hahm DH
J Appl Microbiol; 2015 Aug; 119(2):560-70. PubMed ID: 25968453
[TBL] [Abstract][Full Text] [Related]
49. A selective, high affinity 5-HT 2B receptor antagonist inhibits visceral hypersensitivity in rats.
Ohashi-Doi K; Himaki D; Nagao K; Kawai M; Gale JD; Furness JB; Kurebayashi Y
Neurogastroenterol Motil; 2010 Feb; 22(2):e69-76. PubMed ID: 19740115
[TBL] [Abstract][Full Text] [Related]
50. Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Biomed Pharmacother; 2021 Jul; 139():111649. PubMed ID: 33957565
[TBL] [Abstract][Full Text] [Related]
51. A Monoclonal Anti-Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity.
Noor-Mohammadi E; Ligon CO; Mackenzie K; Stratton J; Shnider S; Greenwood-Van Meerveld B
J Pharmacol Exp Ther; 2021 Nov; 379(3):270-279. PubMed ID: 34620725
[TBL] [Abstract][Full Text] [Related]
52. Visceral hypersensitivity in irritable bowel syndrome.
Kanazawa M; Hongo M; Fukudo S
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
[TBL] [Abstract][Full Text] [Related]
53. Influence of a new 5-HT4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation.
Gilet M; Eutamene H; Han H; Kim HW; Bueno L
Neurogastroenterol Motil; 2014 Dec; 26(12):1761-70. PubMed ID: 25316608
[TBL] [Abstract][Full Text] [Related]
54. A novel TRPV1 receptor antagonist JNJ-17203212 attenuates colonic hypersensitivity in rats.
Wiskur BJ; Tyler K; Campbell-Dittmeyer K; Chaplan SR; Wickenden AD; Greenwood-Van Meerveld B
Methods Find Exp Clin Pharmacol; 2010 Oct; 32(8):557-64. PubMed ID: 21132125
[TBL] [Abstract][Full Text] [Related]
55. Colonic N-methyl-d-aspartate receptor contributes to visceral hypersensitivity in irritable bowel syndrome.
Qi Q; Chen F; Zhang W; Wang P; Li Y; Zuo X
J Gastroenterol Hepatol; 2017 Apr; 32(4):828-836. PubMed ID: 27575648
[TBL] [Abstract][Full Text] [Related]
56. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
57. The comprehensive pathophysiological changes in a novel rat model of postinflammatory visceral hypersensitivity.
Ma J; Li J; Qian M; He N; Cao Y; Liu Y; Wu K; He S
FASEB J; 2019 Dec; 33(12):13560-13571. PubMed ID: 31570003
[TBL] [Abstract][Full Text] [Related]
58. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
Bixquert Jiménez M
Rev Esp Enferm Dig; 2009 Aug; 101(8):553-64. PubMed ID: 19785495
[TBL] [Abstract][Full Text] [Related]
59. Pregabalin inhibits accelerated defecation and decreased colonic nociceptive threshold in sensitized rats.
Ohashi-Doi K; Gale JD; Kurebayashi Y
Eur J Pharmacol; 2010 Sep; 643(1):107-12. PubMed ID: 20598680
[TBL] [Abstract][Full Text] [Related]
60. Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension.
Saito-Nakaya K; Hasegawa R; Nagura Y; Ito H; Fukudo S
Neurogastroenterol Motil; 2008 Oct; 20(10):1147-56. PubMed ID: 18761632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
